About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 927323, 4 pages
http://dx.doi.org/10.1155/2013/927323
Research Article

A Simple Assay to Screen Antimicrobial Compounds Potentiating the Activity of Current Antibiotics

1Department of Biological and Biomedical Sciences, Aga Khan University, Stadium Road, Karachi 74800, Pakistan
2Department of Microbiology, University of Karachi, Karachi 75270, Pakistan

Received 9 April 2013; Revised 29 May 2013; Accepted 4 June 2013

Academic Editor: Kuo-Chen Chou

Copyright © 2013 Junaid Iqbal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Butler and A. D. Buss, “Natural products—the future scaffolds for novel antibiotics?” Biochemical Pharmacology, vol. 71, no. 7, pp. 919–929, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. F. C. Tenover, “Mechanisms of antimicrobial resistance in bacteria,” The American Journal of Medicine, vol. 119, no. 6, pp. S3–S10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. Powers, “Antimicrobial drug development—the past, the present, and the future,” Clinical Microbiology and Infection, vol. 10, no. 4, pp. 23–31, 2004. View at Scopus
  4. A. R. Coates, G. Halls, and Y. Hu, “Novel classes of antibiotics or more of the same?” The British Journal of Pharmacology, vol. 163, no. 1, pp. 184–194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. V. M. Dcosta, C. E. King, L. Kalan et al., “Antibiotic resistance is ancient,” Nature, vol. 477, no. 7365, pp. 457–461, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. L. Ho, K. H. Chow, K. Y. Yuen, W. S. Ng, and P. Y. Chau, “Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae,” Journal of Antimicrobial Chemotherapy, vol. 42, no. 1, pp. 49–54, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. National Committee for Clinical Laboratory Standards, “Performance standards for antimicrobial susceptibility testing,” in NCCLS Approved Standard M100-S14, NCCLS, Wayne, Pa, USA, 2004.
  8. S. Donadio, S. Maffioli, P. Monciardini, M. Sosio, and D. Jabes, “Antibiotic discovery in the twenty-first century: current trends and future perspectives,” Journal of Antibiotics, vol. 63, no. 8, pp. 423–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Pestel, E. Martin, C. Aucouturier, J. F. Lemeland, and F. Caron, “In vitro interactions between different β-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 10, pp. 2341–2344, 1995. View at Scopus
  10. S. Rochon-Edouard, M. Pestel-Caron, J. F. Lemeland, and F. Caron, “In vitro synergistic effects of double and triple combinations of β-lactams, vancomycin, and netilmicin against methicillin-resistant Staphylococcus aureus strains,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 11, pp. 3055–3060, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Alkhawajah, “Studies on the antimicrobial activity of Juglans regia,” The American Journal of Chinese Medicine, vol. 25, no. 2, pp. 175–180, 1997. View at Scopus
  12. P. Nancy, M. Manasi, and A. Varghese, “Antiplaque activity of Juglans regia L. and characterization of Juglone from Juglans regia L,” The American Journal of Biochemistry and Biotechnology, vol. 7, no. 1, pp. 29–31, 2011. View at Scopus
  13. K. Bhatia, S. Rahman, M. Ali, and S. Raisuddin, “In vitro antioxidant activity of Juglans regia L. bark extract and its protective effect on cyclophosphamide-induced urotoxicity in mice,” Redox Report, vol. 11, no. 6, pp. 273–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. C. Chou, “Some remarks on predicting multi-label attributes in molecular biosystems,” Molecular BioSystems, vol. 9, no. 6, pp. 1092–1100, 2013.
  15. B. M. Peters, M. E. Shirtliff, and M. A. Jabra-Rizk, “Antimicrobial peptides: primeval molecules or future drugs?” PLoS Pathogens, vol. 6, no. 10, Article ID e1001067, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. G. Perron, M. Zasloff, and G. Bell, “Experimental evolution of resistance to an antimicrobial peptide,” Proceedings of the Royal Society B, vol. 273, no. 1583, pp. 251–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Wang, L. Hu, G. Liu et al., “Prediction of antimicrobial peptides based on sequence alignment and feature selection methods,” PLoS ONE, vol. 6, no. 4, Article ID e18476, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Xiao, P. Wang, W. Z. Lin, J. H. Jia, and K. C. Chou, “iAMP-2L: a two-level multi-label classifier for identifying antimicrobial peptides and their functional types,” Analytical Biochemistry, vol. 436, no. 2, pp. 168–177, 2013. View at Publisher · View at Google Scholar
  19. J. Xu and A. Hagler, “Chemoinformatics and drug discovery,” Molecules, vol. 7, no. 8, pp. 566–600, 2002. View at Scopus
  20. M. Congreve, C. W. Murray, and T. L. Blundell, “Keynote review: structural biology and drug discovery,” Drug Discovery Today, vol. 10, no. 13, pp. 895–907, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Y. Meng, H. X. Zhang, M. Mezei, and M. Cui, “Molecular docking: a powerful approach for structure-based drug discovery,” Current Computer-Aided Drug Design, vol. 7, no. 2, pp. 146–157, 2011. View at Scopus
  22. J. L. Stark and R. Powers, “Application of NMR and molecular docking in structure-based drug discovery,” Topics in Current Chemistry, vol. 326, pp. 1–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Cheng, C. Liu, J. Jiang, et al., “Prediction of drug-target interactions and drug repositioning via network-based inference,” PLOS Computational Biology, vol. 8, no. 5, Article ID e1002503, 2012. View at Publisher · View at Google Scholar
  24. N. S. Buchan, D. K. Rajpal, Y. Webster et al., “The role of translational bioinformatics in drug discovery,” Drug Discovery Today, vol. 16, no. 9-10, pp. 426–434, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. Butte and S. Ito, “Translational bioinformatics: data-driven drug discovery and development,” Clinical Pharmacology and Therapeutics, vol. 91, no. 6, pp. 949–952, 2011. View at Publisher · View at Google Scholar